Oral beclomethasone dipropionate: A critical review of its use in the management of ulcerative colitis and Crohn's disease

Current Clinical Pharmacology

Volumn 7, Issue 2, 2012, Pages 131-136

  Spurio, Federica Fascì ^a   Aratari, Annalisa ^a   Margagnoni, Giovanna ^a   Doddato, Maria Teresa ^a   Chiesara, Francesca ^a   Papi, Claudio ^a  

^a SAN FILIPPO NERI HOSPITAL   (Italy)

Author keywords

Beclomethasone dipropionate; Corticosteroids; Crohn's disease; Ulcerative colitis

Indexed keywords

5 ACETAMIDOSALICYLIC ACID; BECLOMETASONE DIPROPIONATE; BECLOMETHASONE 17 MONOPROPIONATE; BUDESONIDE; CORTICOSTEROID; DEXAMETHASONE; DRUG METABOLITE; MESALAZINE; PLACEBO; PREDNISONE; STEROID; UNCLASSIFIED DRUG;

ADD ON THERAPY; ANTIINFLAMMATORY ACTIVITY; CROHN DISEASE; DRUG BIOAVAILABILITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; DRUG TREATMENT FAILURE; DRUG USE; HUMAN; LOW DRUG DOSE; PRIORITY JOURNAL; REMISSION; REVIEW; ULCERATIVE COLITIS; UNSPECIFIED SIDE EFFECT;

EID: 84860508855     PISSN: 15748847     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488412800228875     Document Type: Review

References (38)

1. Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J 1955; 2: 1041-8.
2. Lennard-Jones JE, Lpngmore AJ, Newell AC, Wilson CW, Jones FA. An assessment of prednisone, salazopyrin, and topical hydrocortisone hemisuccinate used as out-patient treatment for ulcerative colitis. Gut 1960; 1: 217-22.
3. Summers RW, Switz DM, Sessions JT Jr, et al. National Cooperative Crohn's Disease Study: results of drug treatment. Gastroenterology 1979; 77: 847-69.
4. Malchow H, Ewe K, Brandes JW, et al. European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment. Gastroenterology 1984; 86: 249-66.
5. Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults (update). Am J Gastroenterol 2004; 99: 1371-85.
6. Travis SP, Stange EF, Lémann M, et al. European Crohn's and Colitis Organisation (ECCO). European evidence-based Consensus on the management of ulcerative colitis: Current management. J Crohns Colitis. 2008; 2: 24-62.
7. Dignass A, Van Assche G, Lindsay JO, et al. European Crohn's and Colitis Organisation (ECCO). The second European evidencebased Consensus on the diagnosis and management of Crohn's disease: Current management. J Crohns Colitis 2010; 4: 28-62.
8. Mowat C, Cole A, Windsor A, et al. IBD Section of the British Society of Gastroenterology. Guidelines for the management of inflammatory bowel disease in adults. Gut 2011; 60: 571-607.
9. Faubion WA, Loftus EV, Harmsen WS, Zinsmeister AR, Sandborn WJ. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 2001; 121: 255-60.
10. Steinhart AH, Ewe K., Griffiths AM, Modigliani R, Thomsen OO, Corticosteroids for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev 2003; 4: CD000301.
11. Irving PM, Gearry RB, Sparrow MP, Gibson PR. Review article: appropriate use of corticosteroids in Crohn's disease. Aliment Pharmacol Ther 2007; 26: 313-29.
12. Brattsand R. Overview of newer glucocorticosteroid preparations for inflammatory bowel disease. Can J Gastroenterol 1990; 4: 407-14.
13. Campieri M. New steroids and new salicylates in inflammatory bowel disease: a critical appraisal. Gut 2002; 50 Suppl 3: 43-6.
14. Marshall JK, Irvine EJ. Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis. Gut 1997; 40: 775-81.
15. Manguso F, Balzano A. Meta-analysis: the efficacy of rectal beclomethasone dipropionate vs. 5-aminosalicylic acid in mild to moderate distal ulcerative colitis. Aliment Pharmacol Ther 2007; 26: 21-9.
16. Papi C, Luchetti R, Gili L, et al. Budesonide in the treatment of Crohn's disease: a meta-analysis. Aliment Pharmacol Ther 2000; 14: 1419-28.
17. Kane SV, Schoenfeld P, Sandborn WJ, Tremaine W, Hofer T, Feagan BG. The effectiveness of budesonide therapy for Crohn's disease. Aliment Pharmacol Ther 2002; 16: 1509-17.
18. Seow CH, Benchimol EI, Griffiths AM, Otley AR, Steinhart AH. Budesonide for induction of remission in Crohn's disease. Cochrane Database Syst Rev 2008; 3: CD000296.
19. Benchimol EI, Seow CH, Otley AR, Steinhart AH. Budesonide for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev 2009; 1: CD002913.
20. Harris DM. Some properties of beclomethasone dipropionate and related steroids in man. Postgrad Med J 1975; 51: 20-5
21. Steed KP, Hooper G, Ventura P, et al. The in vivo behaviour of a colonic delivery system. Pharmaceutical Profiles Limited study no. PPL-015. Nottingham, 3rd April 1992. Int J Pharm 1994; 112: 199-206.
22. Daley-Yates PT, Price AC, Sisson JR, Pereira A, and Dallow N. Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man. Br J Clin Pharmacol 2001; 51: 400-9.
23. Würthwein G, Rohdewald P. Activation of beclomethasone dipropionate by hydrolysis to beclomethasone-17-monopropionate. Biopharm Drug Dispos 1990; 11: 381-94.
24. Rizzello F, Gionchetti P, D'Arienzo A, et al. Oral beclomethasone dipropionate in the treatment of active ulcerative colitis: a doubleblind placebo-controlled study. Aliment Pharmacol Ther 2002; 16: 1109-16.
25. Sutherland LR, Martin F, Greer S, et al. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology 1987; 92: 1894-8.
26. Campieri M, Adamo S, Valpiani D, et al. Oral beclomethasone dipropionate in the treatment of extensive and left-sided active ulcerative colitis: a multicenter randomised study. Aliment Pharmacol Ther 2003; 17: 1471-80
27. Balzano A, Manguso F, Alberici M, Van Assche G. Efficacy and safety of beclomethasone dipropionate gastro-resistant, prolonged release tablets in mild to moderate ulcerative colitis:the Beta study. J Crohns Colitis 2010; 4: S53
28. Papi C, Aratari A, Moretti A, et al. Oral Beclomethasone Dipropionate as an Alternative to Systemic Steroids in Mild to Moderate Ulcerative Colitis Not Responding to Aminosalicylates. Dig Dis Sci 2010; 55: 2002-7
29. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ 1989; 298: 82-6.
30. Actis GC, Rosina F. Outpatient care for inflammatory bowel disease at a primary referral hospital in Turin. Minerva Gastroenterol Dietol. 2010; 56: 27-34
31. Nunes T, Barreiro-de Acosta M, et al. RECLICU Study Group of GETECCU. Usefulness of oral beclometasone dipropionate in the treatment of active ulcerative colitis in clinical practice: the RECLICU Study. J Crohns Colitis 2010; 4: 629-36.
32. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5 aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987; 317: 1625-9.
33. Astegiano M, Pagano N, Sapone N, et al. Efficacy and safety of oral beclomethasone dipropionate for ileal or ileal-right colon Crohn's disease of mild-to-moderate activity or in remission: Retrospective study. Biomed Pharmacother 2007; 61: 370-6
34. Tursi A, Giorgetti GM, Brandimarte G, Elisei W, Aiello F. Beclomethasone dipropionate for the treatment of mild-to-moderate Crohn's disease: an open-label, budesonide-controlled, randomized study. Med Sci Monit 2006; 12: 29-32.
35. Prantera C, Rizzi M, Cottone M, et al. Beclomethasone dipropionate in Crohn's ileitis: a randomised, double-blind trial. Dig Liver Dis 2011; 43: 59-64.
36. Sandborn WJ, Löfberg R, Feagan BG, Hanauer SB, Campieri M, Greenberg GR. Budesonide for maintenance of remission in patients with Crohn's disease in medically induced remission: a predetermined pooled analysis of four randomized, double-blind, placebo-controlled trials. Am J Gastroenterol. 2005; 100: 1780-7.
37. Cortot A, Colombel JF, Rutgeerts P, et al. Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's disease. Gut 2001; 48: 186-90.
38. Rizzello F, Gionchetti P, Galeazzi R, et al. Oral beclomethasone dipropionate in patients with mild to moderate ulcerative colitis: a dose-finding study. Adv Ther 2001; 18: 261-71.